NCT06640348 is a clinical trial of No intervention in Ovarian Cancer, Epithelial, sponsored by Anhui Provincial Hospital.

Who is sponsoring NCT06640348?

NCT06640348 is sponsored by Anhui Provincial Hospital.

What drugs are being tested in NCT06640348?

Interventions in NCT06640348: No intervention.

What condition does NCT06640348 study?

NCT06640348 studies Ovarian Cancer, Epithelial.

Is NCT06640348 still recruiting?

NCT06640348 is currently recruiting now. Last updated 15 October 2024.

Last reviewed 2024-10-15 · How we verify

NCT06640348

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

Recruiting now Last updated 15 October 2024

What this trial tests

trial testing No intervention in Ovarian Cancer, Epithelial in 70 participants. Currently enrolling.

Timeline

1 January 2025

Primary endpoint
31 December 2027

31 December 2030

Quick facts

Lead sponsor	Anhui Provincial Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 January 2025
Primary completion	31 December 2027
Estimated completion	31 December 2030
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Ovarian Cancer, Epithelial — all drugs for Ovarian Cancer, Epithelial →

Sponsor

Anhui Provincial Hospital

Who can join

Adults 18 to 70, female only, with Ovarian Cancer, Epithelial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is an open, single-center, prospective study aimed at developing high-sensitivity, high-specificity enrichment SERS chips using femtosecond laser processing technology. It involves extracting information from blood samples of ovarian cancer patients and normal controls, specifically identifying cancer and non-cancer signals. The study will construct a statistical algorithm model for the early diagnosis of ovarian cancer, enabling early identification and intervention for ovarian cancer patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Ovarian Cancer, Epithelial

Currently open trials in the same condition.

NCT05107674 — A Study of NX-1607 in Adults With Advanced Malignancies · Phase 1 · recruiting

Other Anhui Provincial Hospital trials

Trials by the same sponsor.

NCT07523464 — Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC · Phase 1 · not yet recruiting
NCT07481656 — Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) · Phase 4 · not yet recruiting
NCT07462676 — Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT. · NA · not yet recruiting
NCT07211048 — Anti CD19 Gene Therapy for B-cell Lymphoma · NA · recruiting
NCT07279844 — An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06640348 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anhui Provincial Hospital
Last refreshed: 15 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06640348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing